The activation of mononuclear phagocytes is a fundamental host defense and homeostatic mechanism which is important to host resistance against cancer and to improved models of immunotherapy of neoplasia. Activation of mononuclear phagocytes is, moreover, important to infection with HIV-1 and the development of AIDS, atherogenesis and chronic inflammatory/destructive disorders such as rheumatoid arthritis. Over the past several years, this group of investigators has developed a well-established model of macrophage activation which is focused upon molecular mechanisms of regulation with particular emphasis upon ligand-receptor interactions, second messengers and genomic regulation. We here propose to employ this experimental model to explore in detail four selected aspects of cellular activation in molecular detail. These studies will provide useful information not only about the activation of mononuclear phagocytes but about topics of general interest to cell and molecular biology. In Project I, regulation and functional/genomic effects of activation of the sodium/hydrogen exchanger or antiport will be explored. In Project II, regulation of class II MHC genes in macrophages, arguably the single-most important antigen processing cell in the body, will be explored in terms of regulation at the genomic level. In Project III, the biologic effects of alpha-2-macroglobulin upon macrophages and suppression of class II MHC molecules will be studied. The active site in the alpha-2-macroglobulin molecule and the interrelationship between it and function too will be explored. In Project IV, the role of low molecular weight guanidine nucleotide binding proteins, resembling products of the proto-oncogene ras, in the development of mononuclear phagocytes as well as their functions such as signal transduction and secretion will be explored. The long-term goal is to establish the regulation of macrophage activation in defined molecular terms and thereby foster the rational development of drugs to manipulate mononuclear phagocytes effectively.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA029589-12
Application #
3093340
Study Section
Special Emphasis Panel (SRC (L1))
Project Start
1981-08-01
Project End
1995-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
12
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Shackelford, R E; Alford, P B; Xue, Y et al. (1997) Aspirin inhibits tumor necrosis factoralpha gene expression in murine tissue macrophages. Mol Pharmacol 52:421-9
Misra, U K; Gonzalez-Gronow, M; Gawdi, G et al. (1997) Up-regulation of the alpha2-macroglobulin signaling receptor on rheumatoid synovial fibroblasts. J Biol Chem 272:497-502
Misra, U K; Gawdi, G; Pizzo, S V (1996) Binding of rat alpha 1-inhibitor-3-methylamine to the alpha 2-macroglobulin signaling receptor induces second messengers. J Cell Biochem 61:61-71
Howard, G C; Roberts, B C; Epstein, D L et al. (1996) Characterization of alpha 2-macroglobulin binding to human trabecular meshwork cells: presence of the alpha 2-macroglobulin signaling receptor. Arch Biochem Biophys 333:19-26
Howard, G C; Yamaguchi, Y; Misra, U K et al. (1996) Selective mutations in cloned and expressed alpha-macroglobulin receptor binding fragment alter binding to either the alpha2-macroglobulin signaling receptor or the low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor. J Biol Chem 271:14105-11
Ali, H; Tomhave, E D; Richardson, R M et al. (1996) Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation. J Biol Chem 271:3200-6
Howard, G C; DeCamp, D L; Misra, U K et al. (1996) Identification of residues in alpha-macroglobulins involved in activation of the alpha 2-macroglobulin signaling receptor. Biochim Biophys Acta 1297:111-4
Howard, G C; Misra, U K; DeCamp, D L et al. (1996) Altered interaction of Cis-dichlorodiammineplatinum(II)--modified alpha 2-macroglobulin (alpha 2M) with the low density lipoprotein receptor-related protein/alpha 2M receptor but not the alpha 2M signaling receptor. J Clin Invest 97:1193-203
Misra, U K; Pizzo, S V (1996) Ligation of the alpha 2-macroglobulin signaling receptor on macrophages induces synthesis of platelet activating factor. J Cell Biochem 61:39-47
Misra, U K; Shackelford, R E; Florine-Casteel, K et al. (1996) Maleylated-BSA induces hydrolysis of PIP2, fluxes of Ca2+, NF-kappaB binding, and transcription of the TNF-alpha gene in murine macrophages. J Leukoc Biol 60:784-92

Showing the most recent 10 out of 151 publications